Patent ID: 8658770

Claim:
An anti-integrin α8β1 antibody selected from the group consisting of: a) an anti-integrin α8β1 antibody comprising: heavy chain CDR1 having the amino acid sequence set forth in SEQ ID No: 1; heavy chain CDR2 having the amino acid sequence set forth in SEQ ID No: 2; heavy chain CDR3 having the amino acid sequence set forth in SEQ ID No: 3; light chain CDR1 having the amino acid sequence set forth in SEQ ID No: 10; light chain having the amino acid sequence set forth in SEQ ID No: 11; and light chain CDR3 having the amino acid sequence set forth in SEQ ID No: 12; b) an anti-integrin α8β1 antibody comprising: heavy chain CDR1 having the amino acid sequence set forth in SEQ ID No: 4; heavy chain CDR2 having the amino acid sequence set forth in SEQ ID No: 5; heavy chain CDR3 having the amino acid sequence set forth in SEQ ID No: 6; light chain CDR1 having the amino acid sequence set forth in SEQ ID No: 13; light chain CDR2 having the amino acid sequence set forth in SEQ ID No: 14; and light chain CDR3 having the amino acid sequence set forth in SEQ ID No: 15; and c) an anti-integrin α8β1 antibody comprising: heavy chain CDR1 having the amino acid sequence set forth in SEQ ID No: 7; heavy chain CDR2 having the amino acid sequence set forth in SEQ ID No: 8; heavy chain CDR3 having the amino acid sequence set forth in SEQ ID No: 9; light chain CDR1 having the amino acid sequence set forth in SEQ ID No: 16; light chain CDR2 having the amino acid sequence set forth in SEQ ID No: 17; and light chain CDR3 having the amino acid sequence set forth in SEQ ID No: 18; or an antigen-binding fragment thereof.